Fluoride drops and tablets are effective caries-inhibiting agents whic
h exercise their benefit through mainly topical means. Results of cari
es trials in which drops or tablets were used in the home vary from ex
cellent to poor, depending on the compliance rates of both parents and
offspring. Delivery in schools has also produced reductions of >80%,
and as poor as 20%, again possibly dependent on teacher vigilance. The
pre-natal controversy re fluoride tablet benefits has only recently b
een tested under a true double-blind protocol and resulted in a non-si
gnificant effect, although the trend was in favour of those whose moth
ers had taken F- tablets during pregnancy. Hence, while at the individ
ual level, the slow intra-oral dissolution of fluoride tablets can be
of great benefit for coronal caries in children, adolescents, and poss
ibly medically compromised adults (with or without root caries), their
contribution on a community basis cannot readily be compared with tha
t of water or salt fluoridation. Although fluoride tablets have been h
eld responsible for an increase in fluorosis prevalence, data which we
re assessed blind now exist to show that a daily dosage of 0.25 mg flu
oride from birth is not asssociated with dental fluorosis, if addition
al fluoride products are not used injudiciously over the same period.